Clinical Trial Update: Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxytocin versus placebo for hyperphagia in children and adolescents with Prader-Willi syndrome has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphagia
• Prader-willi Syndrome

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Prader-Willi Syndrome, Hyperphagia | Phase 2 | Status: COMPLETED | Results posted: 2021-10-07